Skip to main content
Caplight Logo









Emoface

Emoface

Private
GrenobleHealthcare & Life Scienceshttps://emoface.fr

Last Round

Grant

Dec 21, 2023

Total Funding Raised

$176,000

Company Overview

Emoface is an EdTech and MedTech company that develops digital therapy solutions using 3D avatars to support individuals with autism spectrum disorders and socio-emotional difficulties.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Patient Engagement, Vertical SaaS

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

autism spectrum disorderASDdigital healthsocial-emotional learningemotion recognitiontherapeutic softwaregamified learningfacial emotion analysisneurodiversityspeech therapySaaSedtechassistive technologymental health appclinical monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Emoface Comparables

Compare Emoface with similar companies based on industry and business-model similarity.

Emoface comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Auticiel
81%
Otsimo
81%
Brighten Learning, Inc.
79%

Emoface Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 21, 2023
GrantJun 28, 2023
SeedMar 30, 2023
GrantNov 1, 2020
GrantJul 16, 2020

Emoface Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2025

    Monthly visitors grew 361% MoM, reaching 1.6K.

  • Oct 29, 2024

    Monthly visitors increased 45% MoM, from 520 to 756.

Emoface Filings

Explore SEC and related filing metadata, where available.

Emoface filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Emoface's valuation, stock price, and market status.

Is Emoface a public or private company?

Emoface is a private company.

What is the current stock price of Emoface?

Emoface is a private company with no public stock price. No recent secondary market data is available.

How much is Emoface worth (valuation)?

Valuation information for Emoface is not publicly available.

Can I buy Emoface stock?

Emoface shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Emoface's last funding round?

Emoface's most recent funding round was Grant on December 21, 2023.

Who are the main investors in Emoface?

Key investors in Emoface include European Innovation Council, Bpifrance, Région Auvergne-Rhône-Alpes.

Will Emoface IPO soon?

No public IPO plans have been announced for Emoface.

How can I track Emoface secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Emoface's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGrenoble
Employee Range3
Year Founded2020
Last FundingDec 21, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?